ASX - By Stock
|
LKE |
Re:
Ann: Operational Update
|
|
bunyipt
|
100 |
24K |
8 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
100
|
24K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
bunyipt
|
261 |
76K |
6 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
261
|
76K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
bunyipt
|
1.4K |
376K |
10 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
1.4K
|
376K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
bunyipt
|
222 |
51K |
9 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
222
|
51K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
bunyipt
|
222 |
51K |
3 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
222
|
51K
|
3
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
bunyipt
|
222 |
51K |
5 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
222
|
51K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
bunyipt
|
222 |
51K |
3 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
222
|
51K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Updated PAA holders as at 4 March 2024
|
|
bunyipt
|
2 |
1.1K |
5 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
2
|
1.1K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
bunyipt
|
1.4K |
376K |
6 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
1.4K
|
376K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
bunyipt
|
1.4K |
376K |
18 |
08/02/24 |
08/02/24 |
ASX - By Stock
|
1.4K
|
376K
|
18
|
|
ASX - By Stock
|
PAA |
Re:
TOP 200 PAA SHAREHOLDERS AS AT 30 NOVEMBER 2023
|
|
bunyipt
|
2 |
1.3K |
2 |
02/12/23 |
02/12/23 |
ASX - By Stock
|
2
|
1.3K
|
2
|
|
ASX - By Stock
|
PAA Biotech |
Re:
FDA Application for Orphan Drug Designation , PAA, MPL
|
|
bunyipt
|
355 |
71K |
15 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
355
|
71K
|
15
|
|
ASX - By Stock
|
PAA Biotech |
Re:
FDA Application for Orphan Drug Designation , PAA, MPL
|
|
bunyipt
|
355 |
71K |
8 |
25/11/23 |
25/11/23 |
ASX - By Stock
|
355
|
71K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 3Y x 4
|
|
bunyipt
|
3 |
1.1K |
13 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
3
|
1.1K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
bunyipt
|
83 |
16K |
10 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
83
|
16K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
bunyipt
|
83 |
16K |
6 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
83
|
16K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final MND Patient in Cohort 4 Successfully Completes Dosing
|
|
bunyipt
|
125 |
25K |
14 |
13/10/23 |
13/10/23 |
ASX - By Stock
|
125
|
25K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
bunyipt
|
106 |
23K |
9 |
07/10/23 |
07/10/23 |
ASX - By Stock
|
106
|
23K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
TOP 200 PAA SHAREHOLDERS AS AT 29 SEPTEMBER 2023.
|
|
bunyipt
|
6 |
2.0K |
6 |
02/10/23 |
02/10/23 |
ASX - By Stock
|
6
|
2.0K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
$1 party
|
|
bunyipt
|
21 |
4.9K |
2 |
28/09/23 |
28/09/23 |
ASX - By Stock
|
21
|
4.9K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
$1 party
|
|
bunyipt
|
21 |
4.9K |
2 |
28/09/23 |
28/09/23 |
ASX - By Stock
|
21
|
4.9K
|
2
|
|
ASX - By Stock
|
WRK |
Re:
Ann: Contract to uplift Employer Solutions for Link Group
|
|
bunyipt
|
30 |
8.2K |
7 |
25/09/23 |
25/09/23 |
ASX - By Stock
|
30
|
8.2K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Additional Phase 1 data suggest MPL may inhibit MND
|
|
bunyipt
|
380 |
87K |
11 |
14/09/23 |
14/09/23 |
ASX - By Stock
|
380
|
87K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Cohort 3 Pharmacokinetics in MND Patients Completed
|
|
bunyipt
|
140 |
32K |
6 |
17/08/23 |
17/08/23 |
ASX - By Stock
|
140
|
32K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Cohort 3 Pharmacokinetics in MND Patients Completed
|
|
bunyipt
|
140 |
32K |
10 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
140
|
32K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Biomarkers and Pharmacodynamics Results
|
|
bunyipt
|
396 |
86K |
8 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
396
|
86K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Trial Successfully Completes 3rd Patient Cohort
|
|
bunyipt
|
48 |
11K |
6 |
29/07/23 |
29/07/23 |
ASX - By Stock
|
48
|
11K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Motor Neurone Disease Phase 1/2 Clinical Trial Update
|
|
bunyipt
|
165 |
36K |
11 |
20/07/23 |
20/07/23 |
ASX - By Stock
|
165
|
36K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Results show MPL suppresses biomarkers associated with MND
|
|
bunyipt
|
200 |
44K |
9 |
14/07/23 |
14/07/23 |
ASX - By Stock
|
200
|
44K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MPL has anti-cancer effects across multiple cancer types
|
|
bunyipt
|
121 |
27K |
11 |
30/05/23 |
30/05/23 |
ASX - By Stock
|
121
|
27K
|
11
|
|
ASX - By Stock
|
PCL |
Re:
Ann: Completion of PEL 87 3D Seismic Program
|
|
bunyipt
|
622 |
320K |
13 |
28/05/23 |
28/05/23 |
ASX - By Stock
|
622
|
320K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
South Korean Biotech 2023
|
|
bunyipt
|
46 |
9.9K |
7 |
25/05/23 |
25/05/23 |
ASX - By Stock
|
46
|
9.9K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
South Korean Biotech 2023
|
|
bunyipt
|
46 |
9.9K |
5 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
46
|
9.9K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
South Korean Biotech 2023
|
|
bunyipt
|
46 |
9.9K |
7 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
46
|
9.9K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Trial Successfully Completes Second Patient Cohort
|
|
bunyipt
|
52 |
12K |
2 |
11/05/23 |
11/05/23 |
ASX - By Stock
|
52
|
12K
|
2
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Moving Forward , The Countdown Begins
|
|
bunyipt
|
21 |
5.9K |
13 |
07/05/23 |
07/05/23 |
ASX - By Stock
|
21
|
5.9K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
bunyipt
|
56 |
15K |
3 |
28/04/23 |
28/04/23 |
ASX - By Stock
|
56
|
15K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Trial Completes Enrolment of Cohort 2
|
|
bunyipt
|
104 |
28K |
11 |
02/04/23 |
02/04/23 |
ASX - By Stock
|
104
|
28K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Canine Cancer Trial Update
|
|
bunyipt
|
219 |
44K |
8 |
23/03/23 |
23/03/23 |
ASX - By Stock
|
219
|
44K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Investor Webinar Presentation
|
|
bunyipt
|
92 |
19K |
8 |
18/03/23 |
18/03/23 |
ASX - By Stock
|
92
|
19K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
"MPL" a cause of confusion
|
|
bunyipt
|
6 |
1.4K |
6 |
12/03/23 |
12/03/23 |
ASX - By Stock
|
6
|
1.4K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Canine Cancer Trial Update
|
|
bunyipt
|
219 |
44K |
6 |
09/03/23 |
09/03/23 |
ASX - By Stock
|
219
|
44K
|
6
|
|
ASX - By Stock
|
WRK Technology |
Re:
Link Group - Clearing House - CDR
|
|
bunyipt
|
167 |
261K |
3 |
08/03/23 |
08/03/23 |
ASX - By Stock
|
167
|
261K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Pharmaust The Good News , Progress and Moving Forward
|
|
bunyipt
|
64 |
16K |
10 |
28/02/23 |
28/02/23 |
ASX - By Stock
|
64
|
16K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: First Patient of Cohort 2 Dosed in MND Trial
|
|
bunyipt
|
79 |
19K |
3 |
22/02/23 |
22/02/23 |
ASX - By Stock
|
79
|
19K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Interactive AGM Yes/No vote
|
|
bunyipt
|
87 |
13K |
7 |
15/02/23 |
15/02/23 |
ASX - By Stock
|
87
|
13K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
MND PK PD data and why it influences the upcoming Covid-19 trial
|
|
bunyipt
|
40 |
9.6K |
9 |
20/01/23 |
20/01/23 |
ASX - By Stock
|
40
|
9.6K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Trial Successfully Completes First Patient Cohort
|
|
bunyipt
|
164 |
41K |
8 |
15/01/23 |
15/01/23 |
ASX - By Stock
|
164
|
41K
|
8
|
|
ASX - By Stock
|
KDY |
Re:
10-15 Cents by March 2023
|
|
bunyipt
|
219 |
82K |
2 |
07/01/23 |
07/01/23 |
ASX - By Stock
|
219
|
82K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Top 100 PAA Share Holders as at 29th December 2022 with variations
|
|
bunyipt
|
3 |
1.6K |
4 |
31/12/22 |
31/12/22 |
ASX - By Stock
|
3
|
1.6K
|
4
|
|